COKENZEN Side Effects

6942216-6 | Rash Papular
on Jan 13, 2010 Male patient from FRANCE , 60 years of age, was diagnosed with hypertension and was treated with Cokenzen (View Usage). Patient experienced the following unwanted or unexpected effects: rash papular. Cokenzen dosage: 16/12.5 Daily. Patient was hospitalized.

6839666-5 | Dehydration, Diarrhoea, Renal Failure Acute, Vomiting
Patient was taking Cokenzen (View Usage). Patient had the following side effects: dehydration, diarrhoea, renal failure acute, vomiting on Jul 08, 2010 from JAPAN Additional patient health information: Female patient , 84 years of age, was diagnosed with gout (What is gout?) and. Cokenzen dosage: 16/12.5 1 Df Daily. During the same period patient was treated with COLCHIMAX (View Colchimax Review and Colchimax Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), INIPOMP (View Inipomp Review and Inipomp Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), DIAMICRON (View Diamicron Review and Diamicron Label ), XELEVIA (View Xelevia Review and Xelevia Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

6717636-5 | Fall, Hypotension, Malaise, Spinal Compression Fracture, Thoracic Vertebral Fracture
Adverse event was reported on Apr 29, 2010 by a Female patient taking Cokenzen (View Usage) (Dosage: 16/12.5; 1 Dosage Form - Daily.) was diagnosed with hypertension and. Location: JAPAN , 90 years of age, After Cokenzen was administered, patient had the following side effects: fall (What is fall?), hypotension, malaise, spinal compression fracture, thoracic vertebral fracture. During the same period patient was treated with ISOPTIN (View Isoptin Review and Isoptin Label ), VASTAREL (View Vastarel Review and Vastarel Label ), LEXOMIL (View Lexomil Review and Lexomil Label ). Patient was hospitalized.

6567765-4 | Laryngeal Oedema
on Jan 25, 2010 Male patient from SWEDEN , weighting 185.2 lb, was diagnosed with hypertension and was treated with Cokenzen (View Usage). Patient experienced the following unwanted or unexpected effects: laryngeal oedema. Cokenzen dosage: 16/12.5 Mg.


6523829-2 | Decreased Appetite, Hyponatraemia, Malaise, Somnolence
on Dec 24, 2009 Female patient from FRANCE , 74 years of age, was diagnosed with hypertension, type 2 diabetes mellitus and was treated with Cokenzen (View Usage). Patient had the following side effects: decreased appetite, hyponatraemia, malaise, somnolence. Cokenzen dosage: . During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), PREVISCAN (View Previscan Review and Previscan Label ), ACEBUTOLOL (View Acebutolol Review and Acebutolol Label ), CRESTOR (View Crestor Review and Crestor Label ), STABLON (View Stablon Review and Stablon Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), NOVONORM (View Novonorm Review and Novonorm Label ). Patient was hospitalized.

6474566-4 | Dysarthria, Hypoglycaemia
Patient was taking Cokenzen (View Usage). After Cokenzen was administered, patient had the following side effects: dysarthria, hypoglycaemia on Nov 27, 2009 from FRANCE Additional patient health information: Female patient , 74 years of age, was diagnosed with type 2 diabetes mellitus and. Cokenzen dosage: . During the same period patient was treated with ACEBUTOLOL (View Acebutolol Review and Acebutolol Label ), NOVONORM (View Novonorm Review and Novonorm Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), PREVISCAN (View Previscan Review and Previscan Label ), CRESTOR (View Crestor Review and Crestor Label ), STABLON (View Stablon Review and Stablon Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ). Patient was hospitalized.

6370169-0 | Pemphigoid
Adverse event was reported on Sep 14, 2009 by a Female patient taking Cokenzen (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: JAPAN , 67 years of age, Patient experienced the following unwanted or unexpected effects: pemphigoid. During the same period patient was treated with CELIPROLOL (View Celiprolol Review and Celiprolol Label ), STILNOX (View Stilnox Review and Stilnox Label ), MYCOSTER (View Mycoster Review and Mycoster Label ), ROZEX (View Rozex Review and Rozex Label ). Patient was hospitalized.

6228982-6 | Dizziness, Orthostatic Hypotension
on Jun 05, 2009 Male patient from JAPAN , 61 years of age, was diagnosed with hypertension, chronic obstructive pulmonary disease, dyslipidaemia and was treated with Cokenzen (View Usage). Patient had the following side effects: dizziness (What is dizziness?), orthostatic hypotension. Cokenzen dosage: 16/12.5. During the same period patient was treated with LONOTEN (View Lonoten Review and Lonoten Label ), PRAZOSIN HCL (View Prazosin Hcl Review and Prazosin Hcl Label ), ISOPTIN (View Isoptin Review and Isoptin Label ), SYMBICORT (View Symbicort Review and Symbicort Label ), MOPRAL (View Mopral Review and Mopral Label ), TAHOR (View Tahor Review and Tahor Label ), VENTOLIN (View Ventolin Review and Ventolin Label ), TEMESTA (View Temesta Review and Temesta Label ). Patient was hospitalized.

5480542-0 | Caesarean Section, Cervical Incompetence, Premature Rupture Of Membranes, Uterine Disorder
on Sep 28, 2007 Female patient from FRANCE , 39 years of age, weighting 141.1 lb, was diagnosed with hypertension and was treated with Cokenzen (View Usage). After Cokenzen was administered, patient had the following side effects: caesarean section, cervical incompetence, premature rupture of membranes, uterine disorder. Cokenzen dosage: . Patient was hospitalized.

5480540-7 | Cyanosis, Hypotonia
Patient was taking Cokenzen (View Usage). Patient experienced the following unwanted or unexpected effects: cyanosis, hypotonia on Sep 28, 2007 from FRANCE Additional patient health information: Male patient , weighting 6.61 lb, was diagnosed with hypertension and. Cokenzen dosage: . Patient was hospitalized.

5480500-6 | Uterine Disorder
Adverse event was reported on Sep 28, 2007 by a Female patient taking Cokenzen (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: FRANCE , 39 years of age, weighting 141.1 lb, Patient had the following side effects: uterine disorder. Patient was hospitalized.

5480498-0 | Cyanosis, Hypotonia
on Sep 28, 2007 Male patient from FRANCE , weighting 6.61 lb, was diagnosed with hypertension and was treated with Cokenzen (View Usage). After Cokenzen was administered, patient had the following side effects: cyanosis, hypotonia. Cokenzen dosage: . Patient was hospitalized.

5391469-7 | Fall, Renal Failure, Rhabdomyolysis
on Jul 10, 2007 Female patient from FRANCE , 80 years of age, was diagnosed with hypertension and was treated with Cokenzen (View Usage). Patient experienced the following unwanted or unexpected effects: fall (What is fall?), renal failure, rhabdomyolysis. Cokenzen dosage: 8/12.5 Mg. Patient was hospitalized.

5362388-7 | Hypochloraemia, Hyponatraemia, Mania
Patient was taking Cokenzen (View Usage). Patient had the following side effects: hypochloraemia, hyponatraemia, mania on Jun 08, 2007 from FRANCE Additional patient health information: Female patient , 60 years of age, was diagnosed with hypertension, bipolar i disorder and. Cokenzen dosage: . During the same period patient was treated with TRILEPTAL (View Trileptal Review and Trileptal Label ), ATARAX (View Atarax Review and Atarax Label ). Patient was hospitalized.

5354355-4 | Cardiac Failure
Adverse event was reported on Jun 07, 2007 by a Male patient taking Cokenzen (View Usage) (Dosage: 16/12.5 Mg) was diagnosed with hypertension, diabetes mellitus non-insulin-dependent, dyslipidaemia and. Location: FRANCE , 74 years of age, weighting 145.5 lb, After Cokenzen was administered, patient had the following side effects: cardiac failure. During the same period patient was treated with ACTOS (View Actos Review and Actos Label ), ICAZ LP (View Icaz Lp Review and Icaz Lp Label ), LIPANTHYL (View Lipanthyl Review and Lipanthyl Label ).

5352853-0 | Uterine Disorder
on Jun 05, 2007 Female patient from FRANCE , 39 years of age, weighting 141.1 lb, was diagnosed with hypertension and was treated with Cokenzen (View Usage). Patient experienced the following unwanted or unexpected effects: uterine disorder. Cokenzen dosage: . Patient was hospitalized.

5272855-2 | Aspartate Aminotransferase Increased, Eosinophilia, Pyrexia, Rash, Rash Maculo-papular, Toxic Skin Eruption
on Mar 16, 2007 Female patient from FRANCE , 59 years of age, weighting 178.6 lb, was diagnosed with hypertension, basedow's disease, insomnia, migraine (What is migraine?) and was treated with Cokenzen (View Usage). Patient had the following side effects: aspartate aminotransferase increased, eosinophilia, pyrexia, rash (What is rash?), rash maculo-papular, toxic skin eruption. Cokenzen dosage: . During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), KERLONE (View Kerlone Review and Kerlone Label ), STILNOX (View Stilnox Review and Stilnox Label ), ZOMIG (View Zomig Review and Zomig Label ). Patient was hospitalized.

4994942-6 | Condition Aggravated, Photosensitivity Reaction, Psoriasis
Patient was taking Cokenzen (View Usage). After Cokenzen was administered, patient had the following side effects: condition aggravated, photosensitivity reaction, psoriasis on Apr 28, 2006 from FRANCE Additional patient health information: Male patient , 74 years of age, weighting 160.9 lb, was diagnosed with hypertension, malaria prophylaxis and. Cokenzen dosage: . During the same period patient was treated with SAVARINE (View Savarine Review and Savarine Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ). Patient was hospitalized.

4818122-X | Asthenia, Cough, Dyspnoea, Emphysema, Syncope
Adverse event was reported on Oct 21, 2005 by a Male patient taking Cokenzen (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: , weighting 178.6 lb, Patient experienced the following unwanted or unexpected effects: asthenia, cough, dyspnoea, emphysema, syncope. Patient was hospitalized.

4709069-8 | Dialysis, Hepatic Enzyme Increased, Renal Failure Acute, Rhabdomyolysis
on Jun 14, 2005 Female patient from , 49 years of age, was diagnosed with hypertension, hypercholesterolaemia and was treated with Cokenzen (View Usage). Patient had the following side effects: dialysis (What is dialysis?), hepatic enzyme increased, renal failure acute, rhabdomyolysis. Cokenzen dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), HYPERIUM (View Hyperium Review and Hyperium Label ), BEFIZAL (View Befizal Review and Befizal Label ), SOPROL (View Soprol Review and Soprol Label ), NEXEN (View Nexen Review and Nexen Label ). Patient was hospitalized.

4697296-8 | Dialysis, Hepatic Enzyme Increased, Hypotension, Hypothermia, Oedema Peripheral, Renal Failure Acute, Rhabdomyolysis
on Jun 14, 2005 Female patient from , 49 years of age, was diagnosed with hypertension, hypercholesterolaemia and was treated with Cokenzen (View Usage). After Cokenzen was administered, patient had the following side effects: dialysis (What is dialysis?), hepatic enzyme increased, hypotension, hypothermia (What is hypothermia?), oedema peripheral, renal failure acute, rhabdomyolysis. Cokenzen dosage: . During the same period patient was treated with LASILIX (View Lasilix Review and Lasilix Label ), HYPERIUM (View Hyperium Review and Hyperium Label ), BEFIZAL (View Befizal Review and Befizal Label ), SOPROL (View Soprol Review and Soprol Label ), NEXEN (View Nexen Review and Nexen Label ). Patient was hospitalized.

4639188-6 | Antinuclear Antibody Positive, C-reactive Protein Increased, Cytolytic Hepatitis, Cytomegalovirus Antibody Positive, Epstein-barr Virus Antibody Positive, Neutropenia, Normochromic Normocytic Anaemia, Thrombocytopenia
Patient was taking Cokenzen (View Usage). Patient experienced the following unwanted or unexpected effects: antinuclear antibody positive, c-reactive protein increased, cytolytic hepatitis, cytomegalovirus antibody positive, epstein-barr virus antibody positive, neutropenia, normochromic normocytic anaemia, thrombocytopenia on Nov 05, 2004 from Additional patient health information: Female patient , 63 years of age, was diagnosed with hypertension and. Cokenzen dosage: 1 Df Qd Po. During the same period patient was treated with DAKTARIN (View Daktarin Review and Daktarin Label ), STILNOX (View Stilnox Review and Stilnox Label ), RIVOTRIL (5 Gtt Bid Po) (View Rivotril Review and Rivotril Label ). Patient was hospitalized.

4560863-6 | Abnormal Behaviour, Anaemia, Brain Mass, Coprolalia, Disinhibition, Subdural Haematoma
Adverse event was reported on Jan 12, 2005 by a Female patient taking Cokenzen (View Usage) (Dosage: 1 Df Qd Po) was diagnosed with hypertension and. Location: , 76 years of age, Patient had the following side effects: abnormal behaviour, anaemia, brain mass, coprolalia, disinhibition, subdural haematoma. Patient was hospitalized.